姓名：李相威

职称：研究员 博士生导师

学位/学历：医学博士

籍贯：河南省

办公室地址：上海市黄浦区重庆南路280号老红楼406

邮箱：li.xiangwei@sjtu.edu.cn

教育经历

郑州大学公共卫生学院 预防医学学士

哈尔滨医科大学公共卫生学院 流行病与卫生统计学硕士

海德堡大学医学院 流行病学博士

工作经历

先后就职于中国医学科学院/北京协和医学院、海德堡大学医学院/德国癌症研究中心

主要成果

l 第一作者在期刊Lancet Infectious Diseases，JAMA Oncology，Nature Communications，eClinicalMedicine, Journal of Infectious Diseases等发表论文；

l 第一作者SCI累计影响因子>150分（以发表当年影响因子计算），应邀担任European Journal of Epidemiology，BMC Geriatrics，BMC Public Health，BMC Cancer，International Journal of Public Health等期刊审稿人（2023年）；

l 国家留学基金委2022年“国家优秀自费留学生”。

科研方向/主要研究内容

与衰老、老龄人群健康有关的流行病学与分子流行病学研究，主要包括动物健康、环境健康与人群衰老、老龄人群健康的交互作用，基于多组学技术人群衰老有关的生物标志物研究，老龄人群健康规律研究等。

科研项目

国家科技重大专项 “既往肺结核患者潜伏感染干预技术研究（2017ZX10201302-002）”

“肺结核和结核分枝杆菌潜伏感染的干预研究课题（2014ZX10003001）” 、“结核分枝杆菌感染的流行病学调查和队列研究（2013ZX10003004-002）”等项目总协调人/核心成员

发表论文（节选）

1. Li X, Delerue T, Schottker B, et.al. (2022). Derivation and validation of an epigenetic frailty risk score in population-based cohorts of older adults. Nature Communications, 13:5269.

2. Li X, Schottker B, Holleczek B, et.al. (2022). Association of longitudinal repeated measurements of frailty index with mortality: cohort study among community-dwelling older adults. EclinicalMedicine, 53:101630.

3. Li X, Jansen L, Chang-Claude J, et.al. (2022). Risk of Colorectal Cancer Associated With Lifetime Excess Weight. JAMA Oncol, 8(5):730-7.

4. Li X, Schottker B, Holleczek B, et.al. (2022). Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study. EBioMedicine, 81:104083.

5. Li X, Zhang Y, Gao X, et.al. (2021). Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study. EBioMedicine, 74:103686.

小组成员

热忱欢迎您的加入（常年招收博士后）

英文：

Name：Xiangwei Li

Degree：PhD

Title：Professor

Hometown: Henan Province

Email Address: li.xiangwei@sjtu.edu.cn

Office Address: Room 406, Building 1, 280 South Chongqing Road, Shanghai

Education：

Zhengzhou University School of Public Health - Bachelor of Preventive Medicine.

Harbin Medical University School of Public Health - Master of Epidemiology and Health Statistics.

Heidelberg University Medical School - Doctor of Epidemiology.

Appointments：

Employment history includes positions at the Chinese Academy of Medical Sciences/Peking Union Medical College and Heidelberg University School of Medicine/German Cancer Research Center.

Main achievements:

- The first author published papers in journals such as Lancet Infectious Diseases, JAMA Oncology, Nature Communications, eClinicalMedicine, Journal of Infectious Diseases, etc.

- The first author's cumulative impact factor in SCI journals exceeded 150 points (calculated based on the impact factor of the publication year). The author was invited to serve as a reviewer for journals such as European Journal of Epidemiology, BMC Geriatrics, BMC Public Health, BMC Cancer, International Journal of Public Health, etc. (in 2023).

- Awarded the "National Excellent Self-funded Overseas Student" by the China Scholarship Council in 2022.

Research Interest：

Epidemiological and molecular epidemiological research related to aging and the health of the elderly. This includes studies on animal health, the interaction between environmental health and aging in the population, research on biomarkers related to population aging using multi-omics technologies, and the study of patterns of health in the elderly population.